| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |